Switch to:
More From Other Websites
Repros Gets Additional FDA Guidance for Androxal Jul 17 2014
FDA Confirms Sperm and Testosterone Endpoints as Key Parameters for Assessment of Androxal(R) Versus... Jul 16 2014
FDA Confirms Sperm and Testosterone Endpoints as Key Parameters for Assessment of Androxal(R) Versus... Jul 16 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Jul 16 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission... Jun 20 2014
REPROS THERAPEUTICS INC. Financials May 20 2014
Repros Therapeutics reaches enrollment goal in second Androxal study May 13 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure May 13 2014
Repros Fully Enrolls Second Previously Announced Head to Head Study of Androxal(R) Versus the... May 13 2014
Repros' Q1 Loss In Line with Expectations May 13 2014
Repros Therapeutics reports Q1 EPS (37c), consensus (35c) May 12 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition May 12 2014
Repros Therapeutics Inc.(R) Reports First Quarter 2014 Financial Results May 12 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure May 08 2014
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repros... May 05 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Apr 30 2014
Repros Completes Enrollment for Androxal Study Apr 15 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events Apr 14 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers Apr 01 2014
REPROS THERAPEUTICS INC. Financials Mar 19 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide